Anemia and coagulation disorders Anemia is a common complication of moderate to advanced CKD (≥ stage 3) and, when < 10g / dL, is treated with erythropoiesis-stimulating agents (ESA), such as recombinant human erythropoietin (eg, epoetin alfa).